A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factors
✍ Scribed by F. Malekzadeh; T. Marshall; A. Pourshams; M. Gharravi; A. Aslani; A. Nateghi; M. Rastegarpanah; M. Khoshnia; S. Semnani; R. Salahi; G. N. Thomas; B. Larijani; K. K. Cheng; R. Malekzadeh
- Book ID
- 111309348
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 176 KB
- Volume
- 64
- Category
- Article
- ISSN
- 1368-5031
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To conduct a robust, double‐blind, placebo‐controlled study examining the effects of tumor necrosis factor (TNF) modulation on concentrations of traditional and novel cardiovascular disease risk factors in patients with an inflammatory condition. ## Methods In this doubl
## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti